Description

Retatrutide ZPHC  — ახალი თაობის პრეპარატი წონის კლებისთვის

What is Retatrutide?

Retatrutide is an experimental new-generation preparation designed to treat obesity and metabolic issues. It belongs to the so-called «triple agonist» class — meaning it simultaneously acts on three different hormonal receptors:

• GLP-1
• GIP
• Glucagon receptor

Due to this combination, Retatrutide is often called one of the most potent and promising preparations in the field of weight loss. The compound is being developed by Eli Lilly.

How new is this preparation?

Retatrutide is a very new preparation.
Its wide popularity began in 2023 after publication of Phase 2 clinical trial results. At this stage the compound is still undergoing Phase 3 studies and has not yet been fully approved by the FDA.

Nevertheless, Retatrutide is already considered one of the most promising anti-obesity medications in the world because studies have shown exceptionally high weight-loss results.

How does Retatrutide work?

Retatrutide works through several mechanisms simultaneously:

• Reduces appetite
• Increases the feeling of satiety
• Slows gastric emptying
• Improves insulin sensitivity
• Increases energy expenditure and fat burning

The additional activation of the glucagon receptor is what distinguishes it from such popular preparations as:

• Ozempic
• Wegovy
• Mounjaro

Effectiveness — why has Retatrutide become so popular?

In clinical trials Retatrutide has shown very high effectiveness.

In some studies participants lost approximately:

• 22%–24% in 48 weeks
• nearly 29% in 68 weeks

These results are already approaching the effectiveness of bariatric surgery.

In some patients the following was observed:

• Strong appetite control
• Reduced cravings for sweets and processed foods
• Improvement of energy
• Improvement of blood sugar levels

Positive aspects

1. Very strong weight loss

According to current data Retatrutide may become one of the most effective medications against obesity.

2. Strong appetite control

Many people note that their attitude to food changes significantly.

3. Improvement of metabolic health

Studies have shown:

• Improvement of blood sugar
• Increase in insulin sensitivity
• Improvement of fatty liver indicators

4. Once-a-week use

Retatrutide is used as injections and is typically administered once a week.